CD4 and neoplasm: Although tumors can exclude immune cells from entering, once inside, tumors create a hostile environment for immune cells, where antitumor effector cells, CD4+ TH1 cells, CD8+ T cells, and NK cells are at a competitive disadvantage, given the augmented metabolic activity of tumor cells.